Association of Painless Acute Aortic Dissection With Increased Mortality

Seung Woo Park; Hutchison, Stuart; Mahta, Rajendra H.; Isselbacher, Eric M.; Cooper, Jeanna V.; Jianming Fang; Evangelista, Arturo; Llovet, Alfredo; Nienabe, Christoph A.; Suzuki, Toru; Pape, Linda A.; Eagle, Kim A.; Oh, Jae K.
October 2004
Mayo Clinic Proceedings;Oct2004, Vol. 79 Issue 10, p1252
Academic Journal
OBJECTIVE: To evaluate the clinical characteristics and outcomes of patients with painless acute aortic dissection (AAD). PATIENTS AND METHODS: For this study conducted from 1997 to 2001, we searched the International Registry of Acute Aortic Dissection to identify patients with painless AAD (group 1). Their clinical features and in-hospital events were compared with patients who had painful AAD (group 2). RESULTS: Of the 977 patients in the database, 63 (6.4%) had painless AAD, and 914 (93.6%) had painful AAD. Patients in group 1 were older than those In group 2 (mean ± SD age, 66.6±13.3 vs 61.9±14.1 years; P=.01). Type A dissection (involving the ascending aorta or the arch) was more frequent in group 1 (74.6% vs 60.9%; P=.03). Syncope (33.9% vs 11.7%; P<.001), congestive heart faiiure (19.7% vs 3.9%; P<.001), and stroke (11.3% vs 4.7%; P=.03) were more frequent presenting signs in group 1. Diabetes (10.2% vs 4.0%; P=.04), aortic aneurysm (29.5% vs 13.1%; P<.001), ant) prior cardiovascular surgery (48.1% vs 19.7%; P<.001) were also more common in group 1. in-hospital mortality was higher in group 1 (33.3% vs 23.2%; P=.05), especially due to type B dissection (limited to the descending aorta) (43.8% vs 10.4%; P<.001), and the prevalence of aortic rupture was higher among patients with type B dissection in group 1 (18.8% vs 5.9%; P=.04). CONCLUSION: Patients with painless AAD had syncope, congestive heart failure, or stroke. Compared with patients who have painful AAD, patients who have painless AAD have higher mortality, especially when AAD is type B.


Related Articles

  • Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Tien Yin Wong; McIntosh, Rachel // British Medical Bulletin;Jun2005, Vol. 73/74 Issue 1, p57 

    Hypertensive retinopathy has long been regarded as a risk indicator for systemic morbidity and mortality. New population-based studies show that hypertensive retinopathy signs are strongly associated with blood pressure, but inconsistently associated with cholesterol and other risk factors of...

  • COMMENTARY. Falk, Gavin; Fahey, Tom // Evidence Based Medicine;Feb2008, Vol. 13 Issue 1, p24 

    The article comments on a cohort study about the risk of progression to permanent atrial fibrillation (AF), congestive heart failure (CHF), stroke and death in patients with only AF and without structural heart disease by A. Jahangir and colleagues. The author discusses the implications of the...

  • Differential aspects of stroke and congestive heart failure in quality of life reduction: a case series with three comparison groups.  // Health & Quality of Life Outcomes;2011, Vol. 9 Issue 1, p65 

    The article reports on the research related to the assessment of different aspects of strokes and heart diseases and their impact on quality of life reduction. It states that patients suffering from consecutive stroke or congestive heart failure (CHF) have been compared with their caregivers....

  • Management of General Surgical Problems in Patients with Left Ventricular Assist Devices. Eckhauser, A. E.; Melvin, W. V.; Sharp, K. W. // American Surgeon;Feb2006, Vol. 72 Issue 2, p158 

    Congestive heart failure (CHF) is a major health issue resulting in significant patient morbidity and mortality. Left ventricular assist devices (LVADs) are becoming an increasingly popular method of treatment for patients with end-stage CHF. As the use of LVADs increases, there is a greater...

  • Nesiritide for CHF May Increase Mortality Risk. Slawson, David // American Family Physician;8/1/2005, Vol. 72 Issue 3, p510 

    Discusses research being done on the efficacy of nesiritide in the treatment of patients with congestive heart failure. Reference to a study by J. D. Sackner-Bernstein and colleagues published in the April 20, 2005 issue of "Journal of American Medical Association"; Mortality rates among...

  • Validation of Clinical Classification Schemes for Predicting Stroke. Gage, Brian F.; Waterman, Amy D.; Shannon, William; Boechler, Michael; Rich, Michael W.; Radford, Martha J. // JAMA: Journal of the American Medical Association;6/13/2001, Vol. 285 Issue 22, p2864 

    Reports results from the National Registry of Atrial Fibrillation on the validation of clinical classification schemes for predicting stroke. Risk prediction factors including age, coronary artery disease and congestive heart failure; The combination of two existing classification schemes into...

  • The current role of cardiac resynchronization therapy in reducing mortality and hospitalization in heart failure patients: a meta-analysis from clinical trials. Rossi, Andrea; Rossi, Giuseppe; Piacenti, Marcello; Startari, Unberto; Panchetti, Lucia; Morales, Maria-Aurora // Heart & Vessels;Jul2008, Vol. 23 Issue 4, p217 

    Many diagnostic and therapeutic advances have been reached for congestive heart failure (HF). However, despite clinical improvement and longer survival conferred by new pharmacological options, this syndrome is associated with high morbidity and mortality. Atrial-synchronized biventricular...

  • Rhythm control and rate control did not differ for CV mortality in atrial fibrillation and congestive heart failure. Cairns, John // ACP Journal Club;10/21/2008, Vol. 149 Issue 4, p6 

    The article focuses on a study that compared rhythm control with rate control for reducing cardiovascular (CV) mortality in patients with atrial fibrillation (AF) and congestive heart failure (CHF). The study was conducted by researchers D. Roy, M. Talajic and S. Nattel. Rate-control therapy...

  • Should carnitine play a role in cardiac disease management?  // Contemporary OB/GYN;Nov2003, Vol. 48 Issue 11, p116 

    The article reports on the potential of carnitine, a compound similar to amino acid, in improving cardiac function in patients with myocardial infarction and congestive heart failure. In one study, mortality had reached 3 percent among patients who had taken the compound for three months....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics